Inmune Bio's market cap is currently $201.55M. The company's EPS TTM is $-2.183; its P/E ratio is ―; Inmune Bio is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 155.00K	$ 374.00K	$ 181.00K	$ 10.92K	$ 77.69M
Gross Profit	$ 155.00K	$ 374.00K	$ 181.00K	$ 10.92K	$ 77.69M
Operating Income	$ -29.74M	$ -25.95M	$ -29.15M	$ -12.23M	$ -7.76M
EBITDA	$ -29.74M	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Income	$ -30.01M	$ -28.65M	$ -30.34M	$ -12.10M	$ -9.14M
Balance Sheet
Cash & Short-Term Investments	$ 35.85M	$ 52.15M	$ 74.81M	$ 21.97M	$ 7.00M
Total Assets	$ 57.00M	$ 81.80M	$ 99.94M	$ 40.66M	$ 24.47M
Total Debt	$ 10.44M	$ 15.31M	$ 15.23M	$ 160.16K	$ 168.45K
Net Debt	$ -25.41M	$ -36.84M	$ -59.58M	$ -21.81M	$ -6.83M
Total Liabilities	$ 18.86M	$ 21.69M	$ 19.72M	$ 1.90M	$ 860.54K
Stockholders' Equity	$ 38.14M	$ 60.10M	$ 80.22M	$ 38.75M	$ 23.61M
Cash Flow
Free Cash Flow	$ -11.98M	$ -22.69M	$ -43.50M	$ -8.94M	$ -5.38M
Operating Cash Flow	$ -11.98M	$ -22.69M	$ -28.50M	$ -8.94M	$ -5.38M
Investing Cash Flow	$ 0.00	$ 0.00	$ -15.00M	$ 0.00	$ 0.00
Financing Cash Flow	$ -4.22M	$ 729.00K	$ 96.36M	$ 23.89M	$ 12.21M

Currency in USD

Inmune Bio Earnings and Revenue History

Income Statement >

Inmune Bio Debt to Assets

Balance Sheet >

Inmune Bio Cash Flow

Cash Flow >

Inmune Bio Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing